CO4700296A1 - NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION - Google Patents

NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION

Info

Publication number
CO4700296A1
CO4700296A1 CO95060331A CO95060331A CO4700296A1 CO 4700296 A1 CO4700296 A1 CO 4700296A1 CO 95060331 A CO95060331 A CO 95060331A CO 95060331 A CO95060331 A CO 95060331A CO 4700296 A1 CO4700296 A1 CO 4700296A1
Authority
CO
Colombia
Prior art keywords
alkyl
6alkyl
independently hydrogen
conr10
oxygen
Prior art date
Application number
CO95060331A
Other languages
Spanish (es)
Inventor
Laramie Mary Gaster
Francis David King
Paul Adrian Wyman
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to CO95060331A priority Critical patent/CO4700296A1/en
Publication of CO4700296A1 publication Critical patent/CO4700296A1/en

Links

Abstract

Un compuesto de la fórmula (I) o una sal de óxido N del mismo:dondeR1 es hidrógeno, halógeno, alquilo de C1-6 , cicloalquilo de C3-6 , COalquilo de C1-6 , alcoxi de C1-6 , hidroxi, hidrociC1-6 alquilo, hidrociC1-6 alcoxi, alcoxiC1-6 alcoxiC1-6 , acil, nitro, trifluorometil, ciano, SR9 , SOR9 , SO2 R9 , SO2 NR10 R11 , CO2 R10 , NR10 SO2 R11 , CONR10 R11 , CO2 NR10 R11 , CONR10 (CH2 )p CO2 R11 , (CH2 )p NR10R11 , (CH2 )p CONR10 R11 , (CH2 )p NR10 COR11 , (CH2 )p CO2 C1-6 alquilo, CO2 (CH2 )p OR10 , CONHNR10 R11 , NR10 R11 , NR10 CO(CH2 )p NR10 R11, NR10 CONR10 R11 , CR10 =NOR11 , CNR10 =NOR11 , donde R9 , R10 y R11 son independientemente hidrógeno o alquilo de C1-6 y p es 1 a 4; o R1 es un anillo heterocíclico de 5 a 7 miembros sustituído opcionalmente y que contiene de 1 a 4 heteroátomos seleccionados de oxígeno, nitrógeno o sulfuro;R2 y R3 son independientemente hidrógeno, halógeno, alquilo de C1-6 , cicloalquilo de C3-6 , cicloalquenilo de C3-6 , alcoxi de C1-6 , hidroxiC1-6 alquilo, alquiloC1-6 OC1-6 alquilo, acil, arilo, aciloxi, hidroxi, nitro, triofluorometilo, ciano, CO2 R10 , CONR10 R11 , NR10 R11 donde R10 y R11 son independientemente hidrógeno o alquilo de C1-6 ; R4 es hidrógeno o alquilo de C1-6 ;R5 y R6 son independientemente hidrógeno o alquilo de C1-6 ; A es (CR13 R14 )q donde q es 2,3 o 4 y R13 y R14 son independientemente hidrógeno o alquilo de C1-6 o A es (CR13 R14 )r- D donde r es 0,1,2 o 3 y D es oxígeno, sulfuro o CR13 =CR14 .B es oxígeno, CR15 R16 o NR17 donde R15 , R16 y R17 son independientemente hidrógeno o alquiloC1-6 o B es S(O)b donde b es 0,1 o 2;m es 1,2 o 3; yn es 1,2 o 3.A compound of formula (I) or an N-oxide salt thereof: where R1 is hydrogen, halogen, C1-6alkyl, C3-6alkyl, CO1-6alkyl, C1-6alkoxy, hydroxy, hydrocycl1 -6 alkyl, hydrocyC1-6 alkoxy, alkoxyC1-6 alkoxyC1-6, acyl, nitro, trifluoromethyl, cyano, SR9, SOR9, SO2 R9, SO2 NR10 R11, CO2 R10, NR10 SO2 R11, CONR10 R11, CO2 NR10 R11, CONR10 (CH2) p CO2 R11, (CH2) p NR10R11, (CH2) p CONR10 R11, (CH2) p NR10 COR11, (CH2) p CO2 C1-6 alkyl, CO2 (CH2) p OR10, CONHNR10 R11, NR10 R11, NR10 CO (CH2) p NR10 R11, NR10 CONR10 R11, CR10 = NOR11, CNR10 = NOR11, where R9, R10 and R11 are independently hydrogen or C1-6 alkyl and p is 1 to 4; or R1 is an optionally substituted 5 to 7 membered heterocyclic ring containing 1 to 4 heteroatoms selected from oxygen, nitrogen or sulfide; R2 and R3 are independently hydrogen, halogen, C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkenyl, C1-6 alkoxy, hydroxyC1-6 alkyl, C1-6alkyl OC1-6 alkyl, acyl, aryl, acyloxy, hydroxy, nitro, triofluoromethyl, cyano, CO2 R10, CONR10 R11, NR10 R11 where R10 and R11 are independently hydrogen or C1-6alkyl; R4 is hydrogen or C1-6 alkyl, R5 and R6 are independently hydrogen or C1-6 alkyl; A is (CR13 R14) q where q is 2,3 or 4 and R13 and R14 are independently hydrogen or C1-6 alkyl or A is (CR13 R14) r- D where r is 0,1,2 or 3 and D is oxygen, sulfide or CR13 = CR14 .B is oxygen, CR15 R16 or NR17 where R15, R16 and R17 are independently hydrogen or C1-6alkyl or B is S (O) b where b is 0.1 or 2; m is 1 ,2 or 3; and n is 1,2 or 3.

CO95060331A 1995-12-20 1995-12-20 NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION CO4700296A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO95060331A CO4700296A1 (en) 1995-12-20 1995-12-20 NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO95060331A CO4700296A1 (en) 1995-12-20 1995-12-20 NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION

Publications (1)

Publication Number Publication Date
CO4700296A1 true CO4700296A1 (en) 1998-12-29

Family

ID=40930041

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95060331A CO4700296A1 (en) 1995-12-20 1995-12-20 NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION

Country Status (1)

Country Link
CO (1) CO4700296A1 (en)

Similar Documents

Publication Publication Date Title
CO4950609A1 (en) NEW COMPOUNDS
AR002011A1 (en) COMPOUNDS DERIVED FROM PIPERIDINE, ITS SALTS AND N-OXIDES, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS.
ATE169915T1 (en) PYRIMIDINEDIONE DERIVATIVES, THEIR PREPARATION AND USE
CO4950608A1 (en) NEW DERIVATIVES OF PIPERAZINE AND PROCESSES FOR ITS PREPARATION
DK0655996T3 (en) Substituted benzylamino nitrogen-containing, non-aromatic heterocyclic compounds
ATE123771T1 (en) NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE.
CO4950625A1 (en) NICOTINAMIDE DERIVATIVES
FI904327A0 (en) N-SUBSTITUERAD-4-PYRIMIDINAMINER OCH -PYRIMIDINDIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
AR006720A1 (en) A COMPOUND DERIVED FROM HETERO-CYCLIC AZAHEXANE, ITS USE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, PROCEDURE FOR PREPARING IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
NZ518144A (en) Piperazine Compounds
ATE169622T1 (en) HETEROARYLAMINO AND HETEROARYLOXYPYRIDINAMINES AND RELATED COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DK0887344T3 (en) Quinolines and quinazolines useful in therapy
ATE180780T1 (en) 2-(PIPERIDINE-4-YL, PYRIDINE-4-YL AND TETRAHYDROPYRIDINE-4-YL)-BENZOFURAN-7-CARBAMAT DERIVATIVES, THEIR PREPARATION AND USE AS ACETYLCHOLINESTERASE INHIBITORS
NO305174B1 (en) Heterocyclic Compounds
DE69511260D1 (en) Bicyclische amidinderivate als no-synthetase inhibitoren
DE69520279T2 (en) BIBPHENYLAMIDE DERIVATIVES AS 5-HT1D ANTAGONISTS
DK0648760T3 (en) Triazine derivative and its preparation and use
PT90912A (en) PROCESS FOR THE PREPARATION OF THYOPHENOL DERIVATIVES
EA199901096A1 (en) CYANOGUANIDINES AS A CELL PROLIFERATION INHIBITOR
FI903818A0 (en) 1- (PYRIDINYLAMINO) -2-PYRROLIDONER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
MY125037A (en) 1,2,3,4 tetrahydroquinoline derivatives
CO4700296A1 (en) NEW COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS AND THE PROCESS FOR THEIR PREPARATION
DE69328964T2 (en) ARYLINDAZOLINE AND THEIR USE AS HERBICIDES
NO934741L (en) Procedure for minimizing and controlling ischemic and reperfusion injury
ATE148463T1 (en) N-ACYL-SUBSTITUTED AZAZYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS